Cochlear Ltd CHEOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $211.96
- Day Range
- $210.00–210.00
- 52-Week Range
- $145.73–230.46
- Bid/Ask
- $201.00 / $204.00
- Market Cap
- $13.75 Bil
- Volume/Avg
- 6 / 190
Key Statistics
- Price/Earnings (Normalized)
- 57.02
- Price/Sales
- 9.74
- Dividend Yield (Trailing)
- 1.14%
- Dividend Yield (Forward)
- 0.80%
- Total Yield
- 1.29%
Company Profile
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Growth
- Total Number of Employees
- 4,500
- Website
- https://www.cochlear.com
Competitors
Valuation
|
Metric
|
CHEOF
|
RMD
|
SOON
|
|---|---|---|---|
Price/Earnings (Normalized) | 57.02 | 28.85 | 21.47 |
Price/Book Value | 11.41 | 6.61 | 7.23 |
Price/Sales | 9.74 | 6.43 | 4.20 |
Price/Cash Flow | 48.65 | 23.93 | 19.86 |
Price/Earnings
CHEOF
RMD
SOON
Financial Strength
|
Metric
|
CHEOF
|
RMD
|
SOON
|
|---|---|---|---|
Quick Ratio | 1.80 | 1.23 | 0.76 |
Current Ratio | 2.57 | 3.11 | 1.29 |
Interest Coverage | 50.97 | 19.71 | 29.18 |
Quick Ratio
CHEOF
RMD
SOON
Profitability
|
Metric
|
CHEOF
|
RMD
|
SOON
|
|---|---|---|---|
Return on Assets (Normalized) | 14.09% | 14.83% | 11.96% |
Return on Equity (Normalized) | 20.32% | 24.40% | 30.61% |
Return on Invested Capital (Normalized) | 17.67% | 18.31% | 22.85% |
Return on Assets
CHEOF
RMD
SOON
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lztzfttl | Lwtnwbt | $188.9 Bil | |
SYK
| Stryker Corp | Nzjtzbnwg | Wyzc | $129.0 Bil | |
MDT
| Medtronic PLC | Jhdddnxqz | Lpwggn | $106.5 Bil | |
BSX
| Boston Scientific Corp | Fgjftcrf | Mlfhlcd | $100.9 Bil | |
EW
| Edwards Lifesciences Corp | Dmhxfdqbx | Rjygqhp | $53.7 Bil | |
DXCM
| DexCom Inc | Pncpmtfm | Httq | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Cmdhwfsjv | Vcp | $25.5 Bil | |
ALGN
| Align Technology Inc | Fxvjpfht | Dcqkhb | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Wmytxpxh | Ylhqmt | $18.7 Bil | |
PODD
| Insulet Corp | Hcjxpyqry | Bcjygmp | $12.3 Bil |